Evaluation of efficacy of the thiazide diuretic hydrochlorothiazide in mono- and combined therapy in patients with arterial hypertension distributed according to blood rennin-aldosterone profile


Cite item

Full Text

Abstract

We conducted the evaluation of efficacy and the role of the thiazide diuretic hydrochlorothiazide in mono- and combined therapy in patients with arterial hypertension distributed according to blood renin-aldosterone profile. The study included 340 patients with essential hypertension. The plasma renin activity (PRA, range 1,0-3,0 ng/ml/h) and aldosterone plasma levels (range 0,18-0,83 nmol/l or 5-23 ng/ml/h) were evaluated by radioimmunoassay method. Normal range of ratio aldosterone plasma levels to PRA is 5-23. The conclusion of the study is that it possible to give the patients with PRA 0,22-1,0 ng/ml/h and ratio aldosterone plasma levels to PRA 5-50 hydrochlorothiazide in metabolic neutral dose (less then 12,5 mg/day) in monotherapy or in combination with enalapril or losartan in low doses with the titration to achieve blood pressure levels.

References

  1. Рsaty B, Smith N, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. An systemic review meta-analysis. JAMA 1997;277:739-45.
  2. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998;279;1303-07.
  3. SHEP Cooperative Research Group. JAMA 1991;26:3255-64.
  4. Khuri RN, Strieder WN, Giebisch G. Effects of flow rate and potassium intake on distal tubular potassium transfer. Am J Physiol 1975;228(4):1249-61.
  5. Velazquez H, Wright FS. Control by drugs of renal potassium handling. Annu Rev Pharmacol Toxicol 1986;26:293-309.
  6. Zillich AJ, Garg J, Basu S, et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48(2):219-24.
  7. Holland OB, Nixon JV, Kuhnert L. Diuretic-induced ventricular ectopic activity. Am J Med 1981;70(4): 762-68.
  8. Materson BJ, Cushman WC, Goldstein G, et al. Treatment of hypertension in the elderly: I.Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study. Hypertension 1990;15(4):348-60.
  9. McKenney JM, Goodman RP, Wright JT, et al. The effect of low-dose hydrochlorthiazide on blood pressure, serum potassium, and lipoproteins. Pharmacotherapy 1986;6(4):179-84.
  10. Jounela AJ, Lilja M, Lumme J, et al. Relation between low dose of hydrochlorthiazide, antihypertensive effect and adverse effects. Blood press 1994;3(4):231-35.
  11. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiolody. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007;25:1105-87.
  12. Morgan DB, Davidson C. Hypokaliemia and diuretics: an analysis of publications. Br Med J 1980;280(6218):905-08.
  13. Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999;100(12):1311-15.
  14. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and risk primary cardiac arrest. N Engl J Med 1994;330(26):1852-57.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies